RBC Capital analyst Ben Hendrix lowered the firm’s price target on CVS Health (CVS) to $58 from $68 and keeps an Outperform rating on the ...
Walmart and Target will report earnings next week, providing fresh insight into how Americans are faring shortly after retail ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback